NPS Pharmaceuticals Revenue, Growth & Competitor Profile

DBA NPS PHARMACEUTICALS HEALTH AND WELFARE PLAN

Company Profile & Annual Report for NPS Pharmaceuticals

Access the complete profile.

NPS Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	300 Shire Way Lexington, MA 02421

Note: Revenues for privately held companies are statistical evaluations.


NPS Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • NPS Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • NPS Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

NPS Pharmaceuticals Annual Revenue and Growth Rate

NPS Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$100 - $500 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: NPS Pharmaceuticals's revenues are gauged from an analysis of company filings.

NPS Pharmaceuticals's Income Statement (based on Industry Averages)

NPS Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that NPS Pharmaceuticals is developing and marketing. NPS Pharmaceuticals doesn't have any recent trademark applications, indicating NPS Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia	03/22/2016
NATPARA (PARATHYROID HORMONE) FOR INJECTION Pharmaceutical preparations including parathyroid hormone for the treatment or prevention of hypoparathyroidism, diseases involving calcium regulation, diseases involving varying levels of calcium in cells and outside cells, endocrine disorders, or bone metabolism disorders	01/30/2015
SBS QOL Electronic instructional materials in the form of pre-recorded CDs, DVDs and videotapes featuring medicine and science	10/29/2014

See all trademarks and details in the Full Report.

Market Share of NPS Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as NPS Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to NPS Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ELEVATEBIO IPSC	Waltham, MA	100
IMMUNOGEN	Waltham, MA	36
BOSTON IVF	Waltham, MA	34
NPS PHARMACEUTICALS	Lexington, MA	32
CLINICAL SERVICES CORPORATE OPERATIONS	Waltham, MA	20
FOSTER-MILLER	Waltham, MA	15

Other Companies at 300 Shire Way, Lexington MA

Company	Headquarters	Revenue ($ MM)
SHIRE US	Lexington, MA	0
VIROPHARMA	Lexington, MA	0

Future Competition: NPS Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as NPS Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)